These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8067959)

  • 1. Combining lithium and sodium valproate for bipolar disorder.
    Mitchell P; Withers K; Jacobs G; Hickie I
    Aust N Z J Psychiatry; 1994 Mar; 28(1):141-3. PubMed ID: 8067959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate in bipolar disorder: the Canadian perspective.
    Joffe RT
    Can J Psychiatry; 1993 Apr; 38(3 Suppl 2):S46-50. PubMed ID: 8098990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate with lithium and carbamazepine in bipolar disorder.
    Freeman MP
    Am J Psychiatry; 1999 May; 156(5):810-1. PubMed ID: 10327939
    [No Abstract]   [Full Text] [Related]  

  • 4. Emerging perspectives on valproate in affective disorders.
    Post RM
    J Clin Psychiatry; 1989 Mar; 50 Suppl():3-9. PubMed ID: 2494156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbamazepine and valproate in the maintenance treatment of bipolar disorder.
    Keck PE; McElroy SL
    J Clin Psychiatry; 2002; 63 Suppl 10():13-7. PubMed ID: 12392348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-lithium treatment for bipolar disorder.
    Post RM
    J Clin Psychiatry; 1990 Aug; 51 Suppl():9-16; discussion 17-9. PubMed ID: 2116406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sucralfate in bipolar patients with valproate intolerance.
    Blum LD
    J Clin Psychiatry; 1995 Sep; 56(9):432. PubMed ID: 7665544
    [No Abstract]   [Full Text] [Related]  

  • 8. Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder.
    Denicoff KD; Smith-Jackson EE; Bryan AL; Ali SO; Post RM
    Am J Psychiatry; 1997 Oct; 154(10):1456-8. PubMed ID: 9326833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate.
    Sokolski KN; Denson TF
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):863-6. PubMed ID: 12921920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term use of valproate in primary psychiatric disorders.
    Hayes SG
    J Clin Psychiatry; 1989 Mar; 50 Suppl():35-9. PubMed ID: 2494158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial triple therapy of acute mania, adding lithium and valproate to neuroleptics.
    Reischies FM; Hartikainen J; Berghöfer AM
    Pharmacopsychiatry; 2002 Nov; 35(6):244-6. PubMed ID: 12518274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initial lithium and valproate combination therapy in acute mania.
    Reischies FM; Hartikainen J; Berghöfer A
    Neuropsychobiology; 2002; 46 Suppl 1():22-7. PubMed ID: 12571429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quetiapine and classical mood stabilizers in the long-term treatment of Bipolar Disorder: a 4-year follow-up naturalistic study.
    Altamura AC; Mundo E; Dell'Osso B; Tacchini G; Buoli M; Calabrese JR
    J Affect Disord; 2008 Sep; 110(1-2):135-41. PubMed ID: 18329720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case of bipolar disorder successfully stabilized with clonazepam, valproate and lithium after numerous relapses for 47 years.
    Mashiko H; Kurita M; Shirakawa H; Ohtomo K; Hashimoto M; Miyashita N; Niwa S
    Psychiatry Clin Neurosci; 2004 Jun; 58(3):340-1. PubMed ID: 15149305
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders.
    Emrich HM; Dose M; von Zerssen D
    J Affect Disord; 1985; 8(3):243-50. PubMed ID: 3160736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients.
    Silverstone PH; Wu RH; O'Donnell T; Ulrich M; Asghar SJ; Hanstock CC
    Hum Psychopharmacol; 2002 Oct; 17(7):321-7. PubMed ID: 12415549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The psychopharmacologic specificity of the lithium ion: origins and trajectory.
    Soares JC; Gershon S
    J Clin Psychiatry; 2000; 61 Suppl 9():16-22. PubMed ID: 10826656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in pharmacotherapy of Schizoaffective and bipolar affective disorders: a 5-year naturalistic study.
    Fenn HH; Robinson D; Luby V; Dangel C; Buxton E; Beattie M; Kraemer H; Yesavage JA
    Am J Psychiatry; 1996 May; 153(5):711-3. PubMed ID: 8615421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH; McNamara RK; Watterson JM; Watson DG
    J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.